Study raises more concerns about SSRIs and birth defects
More evidence supports the theory that exposure to a class of antidepressants during the first trimester of pregnancy increases the risk for major congenital anomalies, particularly cardiac defects. A Finnish study conducted by the Teratology Information Service at the Helsinki University Central Hospital confirms the results of other research showing increased risks for specific birth defects in fetuses exposed to selective serotonin reuptake inhibitors, or SSRIs, during gestation.

